News
In March, two biotechnology companies were given the greenlight by the Food and Drug Administration, or FDA, to conduct trials transplanting genetically-modifie ...
New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how ...
In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...
Key takeawaysUCLA researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as ...
Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost ...
Carla Nester, MD, MSA, FASN, is coinvestigator for the ongoing APPEAR-C3G trial (NCT04817618), data from which were used to ...
In this video, Girish N Nadkarni, MD, a professor of medicine at the Icahn School of Medicine at Mount Sinai, discusses recent advancements in chronic kidney disease care.
Novo Nordisk Raises Awareness of Chronic Kidney Disease & Type 2 Diabetes Treatment Option, Ozempic®
March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results